US Stock MarketDetailed Quotes
IPA ImmunoPrecise Antibodies
- 1.370
- +0.050+3.79%
Trading Apr 29 13:34 ET
36.05MMarket Cap-3285P/E (TTM)
1.390High1.330Low25.72KVolume1.370Open1.320Pre Close35.01KTurnover0.11%Turnover RatioLossP/E (Static)26.32MShares4.22052wk High0.99P/B31.23MFloat Cap0.94052wk Low--Dividend TTM22.79MShs Float33.340Historical High--Div YieldTTM4.55%Amplitude0.940Historical Low1.361Avg Price1Lot Size
ImmunoPrecise Antibodies Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q4)Apr 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.31%6.22M | 18.63%6.15M | 21.31%5.69M | 6.72%20.67M | 7.29%5.62M | 7.39%5.17M | 9.78%5.18M | 2.20%4.69M | 8.11%19.36M | 7.42%5.24M |
| Operating revenue | 20.31%6.22M | 18.63%6.15M | 21.31%5.69M | 6.72%20.67M | 7.29%5.62M | 7.39%5.17M | 9.78%5.18M | 2.20%4.69M | 8.11%19.36M | 7.42%5.24M |
| Cost of revenue | 37.02%3.02M | 32.89%3.2M | 30.90%2.89M | 8.60%9.1M | 18.56%2.28M | -0.99%2.21M | 12.02%2.41M | 6.15%2.21M | 31.49%8.38M | -8.43%1.92M |
| Gross profit | 7.86%3.2M | 6.30%2.95M | 12.75%2.8M | 5.28%11.56M | 0.75%3.34M | 14.62%2.96M | 7.92%2.78M | -1.08%2.48M | -4.81%10.98M | 19.41%3.32M |
| Operating expense | -13.09%6.54M | -43.71%5.96M | -45.53%6.69M | 43.85%39.78M | 23.81%9.39M | 9.70%7.52M | 46.18%10.59M | 108.83%12.28M | 76.00%27.66M | 44.54%7.58M |
| Selling and administrative expenses | -2.45%4.83M | -9.01%4.23M | 8.03%5.68M | 29.71%23.42M | 55.93%9.01M | 14.19%4.95M | 25.11%4.65M | 30.63%5.25M | 36.11%18.06M | 28.41%5.78M |
| -Selling and marketing expense | -22.37%649K | 12.73%921K | 4.01%1.06M | 34.73%3.61M | 8.10%934K | 2.96%836K | 41.84%817K | 526.99%1.02M | 287.55%2.68M | 364.52%864K |
| -General and administrative expense | 1.61%4.18M | -13.65%3.31M | 9.00%4.61M | 28.84%19.81M | 64.34%8.07M | 16.79%4.11M | 22.05%3.83M | 9.67%4.23M | 22.29%15.38M | 13.91%4.91M |
| Research and development costs | -35.96%1M | -79.27%1.04M | -92.74%449K | 60.25%12.28M | -168.66%-909K | -24.05%1.56M | 64.32%5M | 452.73%6.19M | 288.20%7.66M | 114.94%1.32M |
| Depreciation amortization depletion | -31.36%709K | -25.39%711K | -23.83%847K | 119.27%4.41M | 162.35%1.32M | 105.78%1.03M | 89.09%953K | 65.97%1.11M | -26.45%2.01M | -17.97%502K |
| -Depreciation and amortization | -31.36%709K | -25.39%711K | -23.83%847K | 119.27%4.41M | 162.35%1.32M | 105.78%1.03M | 89.09%953K | 65.97%1.11M | -26.45%2.01M | -17.97%502K |
| Other operating expenses | ---- | -14.29%-16K | -4.81%-283K | -342.67%-332K | -36.84%-26K | 38.89%-22K | 26.32%-14K | -485.71%-270K | 96.68%-75K | 96.04%-19K |
| Operating profit | 26.72%-3.34M | 61.50%-3.01M | 60.27%-3.89M | -69.25%-28.22M | -41.73%-6.05M | -6.72%-4.56M | -67.27%-7.81M | -190.43%-9.8M | -299.26%-16.67M | -72.79%-4.27M |
| Net non-operating interest income expense | -105.13%-2K | 477.78%208K | 2,860.00%138K | 23.71%240K | 91.01%170K | -71.94%39K | 357.14%36K | 94.95%-5K | 133.39%194K | 119.65%89K |
| Non-operating interest income | -92.31%3K | 491.67%213K | --143K | -3.23%270K | 80.73%197K | -75.63%39K | 500.00%36K | ---- | -1.06%279K | 139.64%109K |
| Non-operating interest expense | --5K | --5K | 0.00%5K | -64.71%30K | 35.00%27K | --0 | --0 | -95.15%5K | -90.15%85K | -88.76%20K |
| Other net income (expense) | -51.32%-115K | -29.63%209K | -408.70%-71K | -64.03%227K | 91.05%-17K | -114.79%-76K | 318.38%297K | -94.68%23K | 150.97%631K | 82.55%-190K |
| Gain on sale of security | -51.32%-115K | -29.63%209K | -408.70%-71K | -64.03%227K | 91.05%-17K | -114.79%-76K | 318.38%297K | -94.64%23K | 151.13%631K | 82.11%-190K |
| Income before tax | 24.77%-3.46M | 65.36%-2.59M | 60.89%-3.83M | -75.11%-27.75M | -34.95%-5.9M | -27.00%-4.6M | -55.16%-7.48M | -221.63%-9.78M | -164.35%-15.85M | -8.90%-4.37M |
| Income tax | -597.12%-517K | 125.40%32K | 34.99%-262K | -238.44%-1.19M | -378.91%-767K | -50.00%104K | -166.32%-126K | -314.36%-403K | -35.99%861K | -73.07%275K |
| Net income | 37.43%-2.94M | 64.33%-2.62M | 62.00%-3.57M | -58.96%-26.56M | -10.44%-5.13M | -22.82%-4.7M | -46.76%-7.35M | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M |
| Net income continuous Operations | 37.43%-2.94M | 64.33%-2.62M | 62.00%-3.57M | -58.96%-26.56M | -10.44%-5.13M | -22.82%-4.7M | -46.76%-7.35M | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 37.43%-2.94M | 64.33%-2.62M | 62.00%-3.57M | -58.96%-26.56M | -10.44%-5.13M | -22.82%-4.7M | -46.76%-7.35M | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 37.43%-2.94M | 64.33%-2.62M | 62.00%-3.57M | -58.96%-26.56M | -10.44%-5.13M | -22.82%-4.7M | -46.76%-7.35M | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M |
| Basic earnings per share | 42.11%-0.11 | 66.67%-0.1 | 63.16%-0.14 | -25.88%-1.07 | 8.70%-0.21 | 5.00%-0.19 | -15.38%-0.3 | -123.53%-0.38 | -88.89%-0.85 | 23.33%-0.23 |
| Diluted earnings per share | 42.11%-0.11 | 66.67%-0.1 | 63.16%-0.14 | -25.88%-1.07 | 8.70%-0.21 | 5.00%-0.19 | -15.38%-0.3 | -123.53%-0.38 | -88.89%-0.85 | 23.33%-0.23 |
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
